MENU
+Compare
IVA
Stock ticker: NASDAQ
AS OF
Jul 21 closing price
Price
$3.30
Change
-$0.09 (-2.65%)
Capitalization
445.44M

IVA Inventiva SA Forecast, Technical & Fundamental Analysis

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation... Show more

IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IVA with price predictions
Jul 18, 2025

IVA in -2.08% downward trend, sliding for three consecutive days on July 17, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IVA declined for three days, in of 271 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for IVA crossed bearishly below the 50-day moving average on June 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for IVA entered a downward trend on July 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where IVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 08, 2025. You may want to consider a long position or call options on IVA as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IVA just turned positive on July 08, 2025. Looking at past instances where IVA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

IVA moved above its 50-day moving average on July 18, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IVA advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

IVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). IVA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (18.450) is also within normal values, averaging (270.975).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IVA is expected to report earnings to fall 66.77% to -60 cents per share on September 25

Inventiva SA IVA Stock Earnings Reports
Q2'25
Est.
$-0.60
Q4'24
Missed
by $1.39
Q3'24
Missed
by $0.20
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.04
The last earnings report on March 26 showed earnings per share of -182 cents, missing the estimate of -43 cents. With 8.72K shares outstanding, the current market capitalization sits at 445.44M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
50 rue de Dijon
Phone
+33 380447500
Employees
123
Web
https://www.inventivapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LFGCX37.840.25
+0.67%
Lord Abbett Focused Growth C
RPBAX28.130.08
+0.29%
T. Rowe Price Balanced
FAOCX35.22N/A
N/A
Fidelity Advisor Overseas C
PSSMX25.84-0.07
-0.27%
Principal SmallCap S&P 600 Index R3
PCSVX17.01-0.08
-0.47%
PACE Small/Medium Co Value Equity P

IVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IVA has been loosely correlated with TVGN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if IVA jumps, then TVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVA
1D Price
Change %
IVA100%
+3.97%
TVGN - IVA
37%
Loosely correlated
-0.81%
IVF - IVA
27%
Poorly correlated
+1.63%
DWTX - IVA
24%
Poorly correlated
+1.47%
CUE - IVA
24%
Poorly correlated
+5.14%
VRCA - IVA
24%
Poorly correlated
-4.55%
More